Clinical Trial Update: Allogeneic MSC Treatment for Pulmonary Emphysema [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating allogeneic mesenchymal stromal cells for pulmonary emphysema.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Emphysema

Drugs mentioned

• Mesenchymal stromal cells

Snippet

Sponsor: Leiden University Medical Center | Conditions: Pulmonary Emphysema, Mesenchymal Stromal Cells | Phase 2 | Status: UNKNOWN